Related references
Note: Only part of the references are listed.Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy
Muayad F. Almahariq et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2018)
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Axillary Nodal Management Following Neoadjuvant Chemotherapy A Review
Melissa Pilewskie et al.
JAMA ONCOLOGY (2017)
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy
Young-Joon Kang et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members
Abigail S. Caudle et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
Hiba El Hage Chehade et al.
AMERICAN JOURNAL OF SURGERY (2016)
The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis
C. G. Rusthoven et al.
ANNALS OF ONCOLOGY (2016)
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment
V. Galimberti et al.
EJSO (2016)
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
Tari A. King et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
Intraoperative frozen section assessment of sentinel lymph nodes in the operative management of women with symptomatic breast cancer
Rohanna Ali et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2008)
Share Paper
